1. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
    Nirmala Chandralega Kampan et al, 2017, Front Immunol CrossRef
  2. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression
    Xiao-Long Fu et al, 2017, Cancer Immunol Immunother CrossRef
  3. Photoelectrochemical immunoassay for human interleukin 6 based on the use of perovskite-type LaFeO3 nanoparticles on fluorine-doped tin oxide glass
    Xing-Pei Liu et al, 2018, Microchim Acta CrossRef
  4. Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
    Daniel E Johnson et al, 2018, Nat Rev Clin Oncol CrossRef
  5. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
    Venus Dalal et al, 2018, Clinica Chimica Acta CrossRef
  6. Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD-L1
    Pei Zhang et al, 2018, Cancer Med CrossRef
  7. Is it the time to study air pollution effects under environmental conditions? A case study to support the shift of in vitro toxicology from the bench to the field.
    Maurizio Gualtieri et al, 2018, Chemosphere CrossRef
  8. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma
    Song Xu et al, 2018, Thorac Cancer CrossRef
  9. Interleukin-6, C/EBP-β and PPAR-γ expression correlates with intramuscular liposarcoma growth in mice: The impact of voluntary physical activity levels
    Mohamad Assi et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  10. null
    Elizabeth Cedars et al, 2018 CrossRef
  11. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma
    Gregory B. Lesinski et al, 2018, Head and Neck Pathol CrossRef
  12. Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer
    Jennifer A. Bridge et al, 2018, Front. Med. CrossRef
  13. Honey activity on the proliferation and migration of oral squamous cell carcinoma: In vitro and bioinformatic analysis
    Macedo Sobrinho Santos Eliane et al, 2018, Sci. Res. Essays CrossRef
  14. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
    Eva A. Ebbing et al, 2019, Proc Natl Acad Sci USA CrossRef
  15. Synthesis and anticancer effects of α-lipoic ester of alloxanthoxyletin
    Wioletta Olejarz et al, 2019, Med Chem Res CrossRef
  16. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis.
    Ethan L Morgan et al, 2019, PLoS Pathog CrossRef
  17. Pleiotropic Effects of Epithelial Mesenchymal Crosstalk on Head and Neck Cancer: EMT and beyond
    T. B. Steinbichler et al, 2019, Cancer Microenvironment CrossRef
  18. Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth
    Xuanhao Li et al, 2019, Cellular Signalling CrossRef
  19. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression
    Jian Gao et al, 2016, J Exp Clin Cancer Res CrossRef
  20. Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma.
    Bowen Yang et al, 2019, Front Oncol CrossRef
  21. IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
    L.P. Stabile et al, 2017, Oral Oncology CrossRef
  22. Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance
    Rachel A. O’Keefe et al, 2020, PLoS ONE CrossRef
  23. The role of bile reflux and its related NF-κB activated pathway in progression of hypopharyngeal squamous cell cancer.
    Clarence T Sasaki et al, 2020, Oral Oncol CrossRef
  24. Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells
    Mohammed L. Ibrahim et al, 2020, Cancer Immunol Immunother CrossRef
  25. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance
    Kevin Dzobo et al, 2020, OMICS: A Journal of Integrative Biology CrossRef
  26. Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma

    Yanping Ji et al, 2020, OTT CrossRef
  27. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
    Ethan L. Morgan et al, 2020, Viruses CrossRef
  28. Combined treatment with acetazolamide and cisplatin enhances the chemosensitivity of human head and neck squamous cell carcinoma TU868 cells
    Tao Jia et al, 2020, Archives of Oral Biology CrossRef
  29. The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles
    Helene Hersvik Aarstad et al, 2020, Biomedicines CrossRef
  30. Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?
    Ethan L. Morgan et al, 2020, Cancers CrossRef
  31. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies
    Yunseo Woo et al, 2020, Cells CrossRef
  32. Cancer-Stimulated CAFs Enhance Monocyte Differentiation and Protumoral TAM Activation via IL6 and GM-CSF Secretion.
    Haaglim Cho et al, 2018, Clin Cancer Res CrossRef
  33. CCDC68 Upregulation by IL-6 Promotes Endometrial Carcinoma Progression
    Xuqing Li et al, 2021, Journal of Interferon & Cytokine Research CrossRef
  34. Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
    Yixiao Qin et al, 2021, Molecular Therapy - Oncolytics CrossRef
  35. Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Uzdan Uz et al, 2021, Clin Exp Otorhinolaryngol CrossRef
  36. Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction
    Till Jasper Meyer et al, 2021, IJMS CrossRef
  37. The intersection of COVID-19 and cancer: signaling pathways and treatment implications
    Zhi Zong et al, 2021, Mol Cancer CrossRef
  38. Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery
    Niels J. van Ruitenbeek et al, 2021, J Neurooncol CrossRef
  39. Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review
    Fatemeh Atashi et al, 2021, J Dent Res Dent Clin Dent Prospects CrossRef
  40. IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives
    Michal Španko et al, 2021, IJMS CrossRef
  41. Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial
    Alexander Rühle et al, 2021, Eur J Nucl Med Mol Imaging CrossRef
  42. Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival
    Ling-Ying Wei et al, 2022, Oral Oncology CrossRef
  43. circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
    Qing Lv et al, 2022, Genetics Research CrossRef
  44. Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer
    Gene Chatman Clark et al, 2022, Front. Oncol. CrossRef
  45. Emission Factors of CO2 and Airborne Pollutants and Toxicological Potency of Biofuels for Airplane Transport: A Preliminary Assessment
    Maurizio Gualtieri et al, 2022, Toxics CrossRef
  46. Suppression of TLR signaling by IRAK-1 and -4 dual inhibitor decreases TPF-resistance-induced pro-oncogenic effects in HNSCC
    Humayara Khan et al, 2023, 3 Biotech CrossRef
  47. Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer
    Stuti Biswal et al, 2023, Archives of Oral Biology CrossRef
  48. Localized Delivery of Erlotinib Using Liposomal Gel Formulations for the Treatment of Oral Squamous Cell Carcinoma
    Kartik Hariharan et al, 2023, International Journal of Pharmaceutics CrossRef
  49. Autocrine IL-6 drives cell and extracellular matrix anisotropy in scar fibroblasts
    Fiona N. Kenny et al, 2023, Matrix Biology CrossRef
  50. Identification of key gene signatures and their characterization by expression correlation with drug sensitivity in smoking-associated oral squamous cell carcinoma
    Pavan Gollapalli et al, 2023 CrossRef
  51. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts.
    Barbora Peltanova et al, 2021, Int J Mol Sci CrossRef